KAHR Receives Investment from Cancer Focus Fund to Support Phase 1/2 Study of KAHR’s Lead Anti-CD47 Candidate in Blood Cancers by rpadmin | May 26, 2021 | Kahr, PR Newswire
Mereo and Focus Fund Announce Etigilimab partnership with MD Anderson by rpadmin | Apr 30, 2021 | Mereo BioPharma
MD Anderson Brings Underdogs into the Fight Against Cancer with Focus Fund by rpadmin | Oct 21, 2020 | BioSpace
Focus Fund and MD Anderson Launch Investment Fund to Support Promising Investigational Cancer Therapies in Early-Stage Clinical Trials by rpadmin | Oct 20, 2020 | PR Newswire